Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease (Q37789693)
Jump to navigation
Jump to search
scientific article published on January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease |
scientific article published on January 2011 |
Statements
1 reference
Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease (English)
1 reference
Edward V Loftus
1 reference
Eric Wu
1 reference
Scott J Johnson
1 reference
Si-Tien Wang
1 reference
Parvez M Mulani
1 reference
Jingdong Chao
1 reference
1 January 2011
1 reference
1 reference
17
1 reference
1
1 reference
127-140
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference